Current - 2 hours ago

Text
Screenshot

Grey lines are ignored Blue lines are triggers

* Portfolio

* Team

* Jobs

* News

* Contact

* Portfolio

* Team

* Jobs

* News

* Contact

Bringing the near future to light.

Our portfolio companies are harnessing the power of cells and computation to reprogram, engineer, scale, digitize, miniaturize, visualize, and grow the future.

* APPIA BIO

Scaling manufacturing to unlock the promise of off-the-shelf cell therapies

* NOETIK

Leveraging advanced machine learning methods to discover and develop cancer immunotherapies

* ZYMOCHEM

Developing microbes and bioprocesses for the sustainable and profitable production of chemicals from renewable resources

* A-ALPHA BIO

Accelerating therapeutic discovery by measuring millions of protein-protein interactions at a time

* TFC THERAPEUTICS

Targeting foundational cancer cells to develop better therapies

* VITRA LABS

Reimagining fertility with next generation IVF

* ENPLUSONE BIO

Harnessing the power and flexibility of enzymes to deliver RNA to the world

* SURF BIO

A stabilization platform that addresses some of drug delivery’s most difficult challenges

* PHANTOM NEURO

Building a system to help people control robotic limbs using low-risk implantable sensors, AI, and enabling software

* CANAERY

Building a nose-computer interface to decode the hidden world of scent

* PARALLEL BIO

Putting the immune system in a dish to improve drug discovery

* INCENDIA THERAPEUTICS

Novel therapeutic platform reprogramming the tumor microenvironment for recalcitrant tumors

* CELLCHORUS

High throughput single-cell analysis for development of cell therapies

* ECOVATIVE DESIGN

Mycelium technology driving plant-based meats, biodegradable packaging and textiles

* STRM.BIO

Leveraging extracellular vesicles to deliver gene therapies in-vivo

* SHIRATRONICS

Novel neuromodulation technologies to combat debilitating migraine headaches

* CHECKERSPOT

Synthetic biology and chemistry to produce novel bio-derived oils from microalgae

* TWELVE

Transforming industrial carbon dioxide emissions into useful chemicals

* IMMUSOFT

Genetically modifying B cells to create sustained, protein-producing therapeutics in the body

* CYTOVALE

Clinical diagnostics to measure biophysical markers of single cells

* MODERN MEADOW

Building enhanced functionality through biofabrication

PREVIOUSLY

Breakout Labs

This isn’t our first rodeo. As founders of Breakout Labs at the Thiel Foundation, we have a long history of investing in and coalescing the ecosystem for early-stage, deep science companies.